November 17, 2020
Factor Bioscience Successfully Defends mRNA Gene Editing Patent
Factor’s Russian Patent No. 2691027 remains fully in force after unsuccessful oppositionPatented compositions include gene-edited hematopoietic cells made using mRNAFactor holds more than 90 patents in 14 countries covering mRNA-related.
February 28, 2023